Inventor · disambiguated record
James Andrew Whitney
Also filed as: WHITNEY JAMES A · WHITNEY JAMES ANDREW
6 granted patents·4 pending applications·24 citations·filing 2007–2024
80Inventor score
Files withGILEAD SCIENCES INC4SIERRA ONCOLOGY INC3CGI PHARMACEUTICALS INC1GLAXOSMITHKLINE LLC1THORNHILL THERAPEUTICS INC1
Top patents by PatentIndex Score
10 records- 0193US9469613B2(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideGILEAD SCIENCES INC·Filed 2015·Granted Oct 18, 2016·15 cites·23 claims
- 0284USRE49445EN-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideSIERRA ONCOLOGY INC·Filed 2020·Granted Mar 7, 2023·1 cites·62 claims
- 0383US9809559B2(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideGILEAD SCIENCES INC·Filed 2016·Granted Nov 7, 2017·3 cites·16 claims
- 0481USRE48285EN-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideSIERRA ONCOLOGY INC·Filed 2018·Granted Oct 27, 2020·2 cites·26 claims
- 0580USRE50497E(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideGLAXOSMITHKLINE LLC·Filed 2023·Granted Jul 22, 2025·0 cites·47 claims
- 0678US10245268B2Treatment of ACVR1-mediated diseasesSIERRA ONCOLOGY INC·Filed 2017·Granted Apr 2, 2019·3 cites·18 claims
- 0762US2015148345A1Therapies for treating myeloproliferative disordersGILEAD SCIENCES INC·Filed 2014·Application pending·0 cites
- 0859US2025235506A1Chimeric il-10/carrier constructs for treatment of pouchitis and methods of useTHORNHILL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0951US2016279135A1Therapies for treating myeloproliferative disordersGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 1045US2010160292A1Kinase Inhibitors, and Methods of Using and Identifying Kinase InhibitorsCGI PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Andrew Whitney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →